Michael A Fischer

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. doi request reprint Academic detailing can play a key role in assessing and implementing comparative effectiveness research findings
    Michael A Fischer
    Harvard Medical School, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Health Aff (Millwood) 31:2206-12. 2012
  2. ncbi request reprint Prior authorization policies for selective cyclooxygenase-2 inhibitors in Medicaid: a policy review
    Michael A Fischer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, 1620 Tremont Street, Boston, MA 02120, USA
    Med Care 44:658-63. 2006
  3. doi request reprint Effect of electronic prescribing with formulary decision support on medication use and cost
    Michael A Fischer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA 02120, USA
    Arch Intern Med 168:2433-9. 2008
  4. pmc Prior authorization for biologic disease-modifying antirheumatic drugs: a description of US Medicaid programs
    Michael A Fischer
    Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02120, USA
    Arthritis Rheum 59:1611-7. 2008
  5. ncbi request reprint Restrictions on antidepressant medications for children: a review of Medicaid policy
    Michael A Fischer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, 1620 Tremont St, Suite 3030, Boston, MA 02120, USA
    Psychiatr Serv 58:135-8. 2007
  6. doi request reprint Trouble getting started: predictors of primary medication nonadherence
    Michael A Fischer
    Department of Medicine, Brigham and Women s Hospital, Boston, MA, USA
    Am J Med 124:1081.e9-22. 2011
  7. ncbi request reprint Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients
    Michael A Fischer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02120, USA
    Arch Intern Med 167:840-6. 2007
  8. ncbi request reprint Impact of Medicaid prior authorization on angiotensin-receptor blockers: can policy promote rational prescribing?
    Michael A Fischer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital Harvard Medical School, Boston, Massachusetts, USA
    Health Aff (Millwood) 26:800-7. 2007
  9. ncbi request reprint The National e-Prescribing Patient Safety Initiative: removing one hurdle, confronting others
    Michael A Fischer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Harvard Medical School, Brigham and Women s Hospital, Boston, Massachusetts 02120, USA
    Drug Saf 30:461-4. 2007
  10. pmc Primary medication non-adherence: analysis of 195,930 electronic prescriptions
    Michael A Fischer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA 02120, USA
    J Gen Intern Med 25:284-90. 2010

Detail Information

Publications58

  1. doi request reprint Academic detailing can play a key role in assessing and implementing comparative effectiveness research findings
    Michael A Fischer
    Harvard Medical School, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Health Aff (Millwood) 31:2206-12. 2012
    ....
  2. ncbi request reprint Prior authorization policies for selective cyclooxygenase-2 inhibitors in Medicaid: a policy review
    Michael A Fischer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, 1620 Tremont Street, Boston, MA 02120, USA
    Med Care 44:658-63. 2006
    ..However, the evidence base for the prior authorization criteria has not been examined previously...
  3. doi request reprint Effect of electronic prescribing with formulary decision support on medication use and cost
    Michael A Fischer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA 02120, USA
    Arch Intern Med 168:2433-9. 2008
    ..In April 2004, 2 large Massachusetts insurers began providing an e-prescribing system with FDS to community-based practices...
  4. pmc Prior authorization for biologic disease-modifying antirheumatic drugs: a description of US Medicaid programs
    Michael A Fischer
    Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02120, USA
    Arthritis Rheum 59:1611-7. 2008
    ..To evaluate state Medicaid prior authorization programs for biologic disease-modifying antirheumatic drugs (DMARDs)...
  5. ncbi request reprint Restrictions on antidepressant medications for children: a review of Medicaid policy
    Michael A Fischer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, 1620 Tremont St, Suite 3030, Boston, MA 02120, USA
    Psychiatr Serv 58:135-8. 2007
    ..This study evaluated Medicaid's prior-authorization policies restricting the prescribing of antidepressant medications for children...
  6. doi request reprint Trouble getting started: predictors of primary medication nonadherence
    Michael A Fischer
    Department of Medicine, Brigham and Women s Hospital, Boston, MA, USA
    Am J Med 124:1081.e9-22. 2011
    ..The advent of electronic prescribing (e-prescribing) systems provides the opportunity to track initial prescriptions and identify nonadherence that may have previously been undetected...
  7. ncbi request reprint Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients
    Michael A Fischer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02120, USA
    Arch Intern Med 167:840-6. 2007
    ..Little is known about the nature of rHuEPO use in hospitalized patients who receive rHuEPO therapy for nononcologic indications...
  8. ncbi request reprint Impact of Medicaid prior authorization on angiotensin-receptor blockers: can policy promote rational prescribing?
    Michael A Fischer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital Harvard Medical School, Boston, Massachusetts, USA
    Health Aff (Millwood) 26:800-7. 2007
    ..3 percent per quarter; alternative approaches were unsuccessful. These findings have important implications for the development of rational drug reimbursement policy under Medicare Part D and other health insurance plans...
  9. ncbi request reprint The National e-Prescribing Patient Safety Initiative: removing one hurdle, confronting others
    Michael A Fischer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Harvard Medical School, Brigham and Women s Hospital, Boston, Massachusetts 02120, USA
    Drug Saf 30:461-4. 2007
  10. pmc Primary medication non-adherence: analysis of 195,930 electronic prescriptions
    Michael A Fischer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA 02120, USA
    J Gen Intern Med 25:284-90. 2010
    ..Little is known about the frequency with which patients fail to fill prescriptions when new medications are started ("primary non-adherence") or predictors of failure to fill...
  11. pmc Uptake of electronic prescribing in community-based practices
    Michael A Fischer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA 02120, USA
    J Gen Intern Med 23:358-63. 2008
    ..In April 2004, 2 large insurers in Massachusetts began a program to fund e-prescribing systems for targeted clinicians and practices. We studied the adoption and uptake of e-prescribing by the targeted prescribers...
  12. ncbi request reprint Conversion from intravenous to oral medications: assessment of a computerized intervention for hospitalized patients
    Michael A Fischer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Departments of Medicine and Emergency Medicine, Brigham and Women s Hospital, Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA
    Arch Intern Med 163:2585-9. 2003
    ..We examined the effect of a computer-based intervention to prompt physicians to switch appropriate patients from intravenous to oral medications...
  13. ncbi request reprint Economic implications of evidence-based prescribing for hypertension: can better care cost less?
    Michael A Fischer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02120, USA
    JAMA 291:1850-6. 2004
    ..Suboptimal prescribing patterns contribute to the high cost of medications for elderly patients as well as the difficulty in providing affordable prescription drug benefits for older Americans...
  14. ncbi request reprint Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit
    Michael A Fischer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
    Pharmacoepidemiol Drug Saf 13:207-14. 2004
    ..Generic medications provide the same clinical effect at lower cost than brand name drugs but little is known about the extent to which such savings are achieved in drug benefit programs serving the elderly...
  15. ncbi request reprint Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors
    Michael A Fischer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02120, USA
    N Engl J Med 351:2187-94. 2004
    ..To control these expenses, many state Medicaid programs have implemented prior-authorization requirements before coxibs can be prescribed. We evaluated the effect of such programs on the use of coxibs by Medicaid beneficiaries...
  16. ncbi request reprint An algorithmic computerised order entry approach to assist in the prescribing of new therapeutic agents: case study of activated protein C at an academic medical centre
    Michael A Fischer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02120, USA
    Drug Saf 27:1253-61. 2004
    ..The cost of the drug is approximately USD 6000-8000 per treated patient. Integration of this product into routine care has produced unique challenges concerning clinical decision making, safety and cost...
  17. ncbi request reprint The hepatotoxicity of antifungal medications in bone marrow transplant recipients
    Michael A Fischer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
    Clin Infect Dis 41:301-7. 2005
    ..Systemic antifungal medications can be lifesaving but can also have important toxicities. With a number of new antifungal drugs being introduced, there is a compelling need to define the toxicities associated with existing therapies...
  18. pmc Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004
    Candace H Feldman
    Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Arthritis Rheum 65:753-63. 2013
    ..This study was undertaken to investigate the epidemiology and sociodemographics of SLE and LN in the low-income US Medicaid population...
  19. pmc State generic substitution laws can lower drug outlays under Medicaid
    William H Shrank
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Health Aff (Millwood) 29:1383-90. 2010
    ..Although these consent requirements are probably intended to increase patient autonomy, policy makers should consider the sizable opportunity costs...
  20. ncbi request reprint Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes
    Wolfgang C Winkelmayer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Am J Kidney Dis 46:1080-7. 2005
    ..However, little is known about the adequacy of adherence to these guidelines in elderly patients with diabetes and predictors of such appropriate ACE-inhibitor or ARB use...
  21. doi request reprint At Pitney Bowes, value-based insurance design cut copayments and increased drug adherence
    Niteesh K Choudhry
    Harvard Medical School, USA
    Health Aff (Millwood) 29:1995-2001. 2010
    ..Our study thus provides an empirical basis for the use of this approach to improve the quality of health care...
  22. pmc Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery
    Brian T Bateman
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Mass 02115, USA
    J Thorac Cardiovasc Surg 146:472-8. 2013
    ..Intravenous vancomycin exposure has been identified as an independent risk factor for CDI, but this is controversial. It is not known whether vancomycin administered for surgical site infection prophylaxis increases the risk of CDI...
  23. doi request reprint The impact of reducing cardiovascular medication copayments on health spending and resource utilization
    Niteesh K Choudhry
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02120, USA
    J Am Coll Cardiol 60:1817-24. 2012
    ..The aim of this study was to evaluate the impact of reductions in statin and clopidogrel copayments on cardiovascular resource utilization, major coronary events, and insurer spending...
  24. doi request reprint Warnings without guidance: patient responses to an FDA warning about ezetimibe
    William H Shrank
    Department of Medicine, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston 02120, USA
    Med Care 50:479-84. 2012
    ..We investigated the proportion of patients who discontinued therapy and switched to a clinically appropriate alternative after the FDA communication...
  25. pmc Modes of delivery for interventions to improve cardiovascular medication adherence
    Sarah L Cutrona
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA, USA
    Am J Manag Care 16:929-42. 2010
    ..To determine the optimal modes of delivery for interventions to improve adherence to cardiovascular medications...
  26. ncbi request reprint Healthcare information technology interventions to improve cardiovascular and diabetes medication adherence
    Alexander S Misono
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA 02120, USA
    Am J Manag Care 16:SP82-92. 2010
    ..To determine the efficacy of healthcare information technology (HIT) interventions in improving adherence...
  27. pmc Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study
    Brian T Bateman
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    BMJ 347:f5416. 2013
    ..To examine the relation between the type of stress ulcer prophylaxis administered and the risk of postoperative pneumonia in patients undergoing coronary artery bypass grafting...
  28. doi request reprint Targeting cardiovascular medication adherence interventions
    Sarah L Cutrona
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, USA
    J Am Pharm Assoc (2003) 52:381-97. 2012
    ..To determine whether adherence interventions should be administered to all medication takers or targeted to nonadherers...
  29. doi request reprint The epidemiology of prescriptions abandoned at the pharmacy
    William H Shrank
    Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02120, USA
    Ann Intern Med 153:633-40. 2010
    ..Understanding the epidemiology and correlates of prescription abandonment may have an important effect on health care quality...
  30. pmc Development of a comorbidity index for use in obstetric patients
    Brian T Bateman
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, The Department of Anesthesiology, Critical Care, and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, and the Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts the Department of Anesthesiology, University of Michigan Health System, Ann Arbor, Michigan and the Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia
    Obstet Gynecol 122:957-65. 2013
    ..To develop and validate a maternal comorbidity index to predict severe maternal morbidity, defined as the occurrence of acute maternal end-organ injury, or mortality...
  31. doi request reprint Comparative effectiveness of preventative therapy for venous thromboembolism after coronary artery bypass graft surgery
    Alexander Kulik
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
    Circ Cardiovasc Interv 5:590-6. 2012
    ..Controversy exists regarding the optimal preventative therapy for venous thromboembolism (VTE) after coronary artery bypass graft (CABG) surgery. We sought to compare the effectiveness and safety of the most commonly used regimens...
  32. ncbi request reprint The implications of therapeutic complexity on adherence to cardiovascular medications
    Niteesh K Choudhry
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Boston, MA 02120, USA
    Arch Intern Med 171:814-22. 2011
    ..Our objective was to estimate the extent of prescribing and filling complexity in patients prescribed a cardiovascular medication and to evaluate its association with adherence...
  33. doi request reprint Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications
    Nihar R Desai
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Boston, MA, USA
    Am J Med 125:302.e1-7. 2012
    ..We aimed to evaluate temporal trends in the use of specific drugs for the initial management of type 2 diabetes and to estimate the economic consequences of non-recommended care...
  34. doi request reprint Patient, physician, and payment predictors of statin adherence
    David C Chan
    Department of Medicine, Division of General Internal Medicine, Brigham and Women s Hospital, Boston, MA, USA
    Med Care 48:196-202. 2010
    ..Although many patient, physician, and payment predictors of adherence have been described, knowledge of their relative strength and overall ability to explain adherence is limited...
  35. pmc Angiotensin inhibition after myocardial infarction: does drug class matter?
    Wolfgang C Winkelmayer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Boston, MA 02120, USA
    J Gen Intern Med 21:1242-7. 2006
    ..Little is known about their relative use after MI in typical care settings, and about their relative effectiveness outside the clinical trial setting...
  36. pmc Is there a relationship between patient beliefs or communication about generic drugs and medication utilization?
    William H Shrank
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02120, USA
    Med Care 47:319-25. 2009
    ..Insurers and policymakers strive to stimulate more cost-effective prescribing and, increasingly, are educating beneficiaries about generics...
  37. pmc Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans
    Michael A Fischer
    Department of Medicine, Brigham and Women s Hospital, Boston, MA 02120, USA
    Health Serv Res 38:1051-63. 2003
    ..To calculate the financial impact of underuse of generic medications in state Medicaid programs...
  38. ncbi request reprint Risk of death in elderly users of conventional vs. atypical antipsychotic medications
    Philip S Wang
    Department of Psychiatry, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
    N Engl J Med 353:2335-41. 2005
    ..However, the advisory did not apply to conventional antipsychotic medications; the risk of death with these older agents is not known...
  39. doi request reprint Are caregivers adherent to their own medications?
    William H Shrank
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02120, USA
    J Am Pharm Assoc (2003) 51:492-8. 2011
    ..To explore caregiver adherence to chronic medications and predictors of appropriate medication use...
  40. doi request reprint The consequences of requesting "dispense as written"
    William H Shrank
    Department of Medicine, Brigham and Women s Hospital, Boston, MA, USA
    Am J Med 124:309-17. 2011
    ..Patients also can make these requests. Little is known about the frequency and correlates of dispense as written requests or their association with medication filling...
  41. doi request reprint Physician perceptions about generic drugs
    William H Shrank
    Brigham and Women s Hospital and Department of Medicine, Division of Pharmacoepidemiology and Pharmacoeconomics, Harvard Medical School, Boston, MA, USA
    Ann Pharmacother 45:31-8. 2011
    ..With constrained health-care resources, there is a need to understand barriers to cost-effective medication use...
  42. ncbi request reprint Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives
    Philip S Wang
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Hypertension 46:273-9. 2005
    ..Highly prevalent, noncardiovascular conditions appear to deter use of antihypertensives in elderly with hypertension...
  43. pmc Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use
    William H Shrank
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, 1620 Tremont St, Suite 3030, Boston, MA 02120, USA
    J Gen Intern Med 22:1298-304. 2007
    ..Increased use of generic medications conserves insurer and patient financial resources and may increase patient adherence...
  44. doi request reprint Risk of fractures in older adults using antihypertensive medications
    Daniel H Solomon
    Division of Rheumatology and Pharmacoepidemiology, Department of Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
    J Bone Miner Res 26:1561-7. 2011
    ..It is concluded that the risk of fracture differs across users of different antihypertensive medications...
  45. ncbi request reprint Medicaid's prior authorization program and access to atypical antipsychotic medications
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Health Aff (Millwood) 26:750-60. 2007
    ..More than a year later, no state had changed its PA policy in response. We discuss the roles of Medicaid and other insurers in responding to emerging drug safety issues and their challenges in weighing drug risks and benefits...
  46. ncbi request reprint Extensions of intellectual property rights and delayed adoption of generic drugs: effects on medicaid spending
    Aaron S Kesselheim
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, in Boston, Massachusetts, USA
    Health Aff (Millwood) 25:1637-47. 2006
    ..The delay in availability, elevated prices, and slow uptake of generic alternatives for these three drugs alone cost Medicaid 1.5 billion dollars in 2000-2004...
  47. pmc Physician effectiveness in interventions to improve cardiovascular medication adherence: a systematic review
    Sarah L Cutrona
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA 02120, USA
    J Gen Intern Med 25:1090-6. 2010
    ..Medications for the prevention and treatment of cardiovascular disease save lives but adherence is often inadequate. The optimal role for physicians in improving adherence remains unclear...
  48. pmc Patterns of outpatient antihypertensive medication use during pregnancy in a Medicaid population
    Brian T Bateman
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Hypertension 60:913-20. 2012
    ..1%) in the third trimester. Antihypertensive use during pregnancy is relatively common and increasing. The wide range of agents used during pregnancy includes medications considered contraindicated during pregnancy...
  49. pmc Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population
    Linda T Hiraki
    Harvard School of Public Health and Brigham and Women s Hospital, Boston, Massachusetts, USA
    Arthritis Rheum 64:2669-76. 2012
    ..To investigate the nationwide prevalence, incidence, and sociodemographics of systemic lupus erythematosus (SLE) and lupus nephritis among children in the US Medicaid beneficiary population...
  50. ncbi request reprint Effect of the Women's Health Initiative on osteoporosis therapy and expenditure in Medicaid
    Jacob A Udell
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02120, USA
    J Bone Miner Res 21:765-71. 2006
    ..Prescribing changes dramatically increased Medicaid spending on osteoporosis therapy over the last decade and requires further evaluation of cost effectiveness...
  51. pmc Patients' perceptions of generic medications
    William H Shrank
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, at Brigham and Women s Hospital Harvard Medical School in Boston, Massachusetts, USA
    Health Aff (Millwood) 28:546-56. 2009
    ..These findings underscore the challenge that providers, insurers, and policymakers face in stimulating the cost-effective use of medications...
  52. ncbi request reprint The rise and fall of Natrecor for congestive heart failure: implications for drug policy
    Aaron S Kesselheim
    Harvard Medical School and Brigham and Women s Hospital, Boston, Massachusetts, USA
    Health Aff (Millwood) 25:1095-102. 2006
    ..Based on the nesiritide experience, we suggest several ways to improve policies for drug approval, postmarketing surveillance, and drug utilization...
  53. ncbi request reprint Strategies for the management of suspected heparin-induced thrombocytopenia: a cost-effectiveness analysis
    Amanda R Patrick
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham, Massachusetts 02120, USA
    Pharmacoeconomics 25:949-61. 2007
    ..Drugs used to treat HIT are costly and may carry an increased risk of bleeding...
  54. doi request reprint Differences between integrated and stand-alone E-prescribing systems have implications for future use
    Catherine M DesRoches
    Mongan Institute for Health Policy, Partners HealthCare, Boston, Massachusetts, USA
    Health Aff (Millwood) 29:2268-77. 2010
    ..Because many stand-alone systems cannot meet meaningful-use requirements, there is likely to be a shift toward integrated systems...
  55. pmc Potential savings from an evidence-based consumer-oriented public education campaign on prescription drugs
    Julie M Donohue
    Department of Health Policy and Management, Graduate School of Public Health, University of Pittsburgh, 130 DeSoto Street, Crabtree Hall A613, Pittsburgh, PA 15261, USA
    Health Serv Res 43:1557-75. 2008
    ..To estimate potential savings associated with the Consumer Reports Best Buy Drugs program, a national educational program that provides consumers with price and effectiveness information on prescription drugs...
  56. ncbi request reprint Topical calcineurin inhibitors for atopic dermatitis: balancing clinical benefit and possible risks
    Abrar A Qureshi
    Arch Dermatol 142:633-7. 2006
  57. ncbi request reprint Topical calcineurin inhibitors revisited
    Abrar Qureshi
    Arch Dermatol 143:545-6. 2007
  58. ncbi request reprint Acute pancreatitis associated with rofecoxib
    Ravi K Amaravadi
    Am J Gastroenterol 97:1077-8. 2002

Research Grants2

  1. Impact of office-based e-prescribing on prescribing processes and outcomes
    Michael Fischer; Fiscal Year: 2007
    ..The findings of this research will provide important lessons for clinicians, researchers, insurers, policy-makers, patients, and all those with an interest in improving the use of prescription drugs. ..
  2. Impact of Medicaid Policy on cardiovascular drug use and clinical outcomes
    Michael A Fischer; Fiscal Year: 2010
    ....